Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
217,101,064
-
Share change
-
+10,250,604
-
Total reported value
-
$3,216,301,753
-
Put/Call ratio
-
53%
-
Price per share
-
$14.82
-
Number of holders
-
266
-
Value change
-
+$212,421,390
-
Number of buys
-
155
-
Number of sells
-
112
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2024
As of 31 Mar 2024,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
266 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
217,101,064 shares.
The largest 10 holders included
VANGUARD GROUP INC, MHR FUND MANAGEMENT LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Artisan Partners Limited Partnership, and JPMORGAN CHASE & CO.
This page lists
266
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.